Snowball logo
logo
6882

Suzhou Zelgen Biopharmaceuticals Co Ltd

688266 SHG
¥111.80+¥3.02  (2.78%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
190.4302.3386.4533812.71,642.5
COGS
7.09895627.5331.4237.7277.63136.1
Gross Profit
183.3274.8355495.2812.71,620.3
Operating Expenses & Income
Operating Income
(459)(485.6)(297.8)(155)(165.8)551
Total Operating Expenses
642.3760.3652.8650.3978.51,020
R&D Expenses
509.4497.7496.3388429.9608.6
Selling General & Admin Expenses
73.8383.2613.0356.05337.7259.4
Earnings from Continuing Operations
Interest Expense
(6.200375)(14.94)(24.45)(29.1)(24.2)(21.63)
Interest Income
39.9828.7539.3558.2955.1240.58
Income Tax Expense
(3.156392)(2.449463)(3.949557)(4.749483)(5.7086)(3.863558)
Net Income
Net Income
(451)(457.3)(278.6)(137.8)(160.7)552.1
Supplemental
EBIT
(458.9)(473)(274.6)(125.9)(166.4)-
EBITDA
(416.7)(420.5)(232.7)(83.03)(123.5)-
In millions of CNY, except % and values per 1 share